Healthcare Professionals
Prescription digital therapy for personalizing insulin therapy every day
EkiYou® supports adults treated with insulin pens on a basal-bolus regimen by calculating personalized insulin doses. EkiYou® also provides weekly adjustments to treatment settings based on glucose, meals, and physical activity data.
CE-marked Class IIb medical device, available by prescription
Compatible with continuous glucose monitors (CGM) available in France
Algorithms for weekly adjustment of insulin therapy parameters
Compatible with the Diabby Healthcare and Glooko XT remote monitoring platforms
Database of over 400,000 verified food items
diabetologists prescribes EkiYou® in France
Bolus doses calculated with EkiYou®
Source: DiappyMed internal data, September 2026
Why prescribe EkiYou®
Discover the clinical data, indications, key features, and prescription details for EkiYou®.
To support patients, EkiYou® offers a wide range of features.
EkiYou® calculates bolus insulin dose.
EkiYou® ncludes adjustment algorithms that, with the patient's consent, enable weekly adjustments to insulin therapy settings (carbohydrate ratios, correction factor, and basal insulin dose).
EkiYou® reminds patients of their scheduled basal insulin dose.
EkiYou® calculates and suggests a correction bolus when the patient enters a high blood glucose value.
EkiYou® also sends a notification reminding the patient to check their blood glucose after a bolus injection.
EkiYou® can connect to continuous glucose monitoring (CGM) systems and remote monitoring platforms.
EkiYou® is a medical device intended for adults with type 1 diabetes, type 2 diabetes, or diabetes secondary to pancreatic disease, treated with insulin pens according to a basal-bolus regimen and monitored by a healthcare professional.
Users must be able to operate a compatible smartphone and follow the instructions in the user manual.
EkiYou® is a digital therapy designed to support adults treated with insulin pens according to a basal-bolus regimen in the daily management of their diabetes.
During initial setup, the patient enters their key insulin therapy parameters, including their carbohydrate ratios, correction factor, and basal insulin dose. If these parameters are not known, setup assistance based on the average total daily dose (TDD) is available directly within the app.
Once configured, EkiYou® takes several everyday factors into account to recommend personalized insulin doses (meal and correction boluses):
- Glucose values, via compatible continuous glucose monitoring (CGM) systems.
- Active insulin.
- Diet, powered by a database of over 400,000 verified foods, visual references to make portion estimation easier, and multiple input methods tailored to each patient's preferences.
- Physical activity, from a wide range of activities, taking their duration and intensity into account.
Based on this information, EkiYou® recommends a personalized insulin dose tailored to the patient's context.
New: Insulin therapy that adapts as needs evolve
Beyond dose calculation, EkiYou® analyzes trends in glucose, meal, and bolus data to suggest adjustments to key insulin therapy parameters, helping to support the patient's evolving needs between consultations.
With the patient's consent, the app can:
Automatically adjust the basal insulin dose¹.
Automatically adjust carbohydrate ratios and the correction factor on a weekly basis².
In this way, EkiYou® supports patients in adapting their treatment over time, while leaving them in full control of the recommendations offered to them.
New: "My Meal Sizes" (PMG): a simplified alternative to carb counting
For patients who prefer not to carry out detailed carbohydrate counting at every meal, EkiYou® offers the "My Meal Sizes" (SML) feature. This feature allows users to simply enter the meal size by selecting one of three available categories:
- Small meal
- Medium meal
- Large meal
This approach simplifies daily food logging while still allowing EkiYou® to recommend an appropriate insulin dose.
New: Data Sharing with Remote Monitoring Platforms
Thanks to data sharing with remote monitoring platforms, gain access to your patients' relevant data to enhance follow-up, facilitate therapy adjustments, and support proactive patient care.
¹By analyzing glucose variations during nighttime periods over the past 14 days.
²By analyzing glucose, boluses, and carbohydrate intake over the past 14 days.
Proven efficacy
Through the EkiYou-Study-1, conducted in France, EkiYou® is the first digital therapy in app form to have demonstrated improved glycemic control¹
Improved time in range¹
Reduced fear of hypoglycemia¹
Easy to get started
Studies have also shown that EkiYou® is easy to set up and that its use helps reduce patients' mental burden:
More than 3 out of 4 patients successfully set up the app without assistance ²
87% of patients felt more confident using the app³
A prospective, multicenter, randomized, controlled clinical study (NCT06738849) has been conducted at several hospital centers specializing in diabetology. Analyses are currently underway.
The primary objective of this study is to assess the impact of EkiYou on Time in Range (TIR). It also aims to measure the durability of performance at 6 months, as well as user satisfaction, quality of life, and engagement with the app.
Would you like to explore our clinical studies, publications, and available results? Visit our science section
¹EkiYou-Study-1 Study, NCT06529705
Regular and correct use of the application allows users to benefit from personalized bolus calculation and was associated, in EkiYou-Study-1, with improved glycemic control in active per-protocol participants:
- Through improved Time in Range, which increased from 44.7% to 51.5%, corresponding to +6.8%, with p=0.0021 in 15 active per-protocol participants.
- Through reduced fear of hypoglycemia, measured by the HFS-II score, which decreased from 35.07 ± 15.3 to 28.07 ± 14.7, corresponding to a -7 point reduction.
- This improvement in glycemic control was observed without increased hypoglycemia exposure.
²Summative usability report, 2025
³GLUCAL 3 Study, NCT05098301
EkiYou® has already been prescribed to many patients.
How to prescribe it?
Paper prescription
View the prescribing guide
EkiYou usage information
A solution built on clinical expertise
Developed with the expertise of healthcare professionals
“EkiYou offers multiple indications for improving diabetes control, which no other tool has been able to address until now“
Prof. Éric Renard
EkiYou is developed in collaboration with a medical committee made up of diabetologists and endocrinologists who are experts in diabetes care.
Pr. Éric Renard
CHU Montpellier, Vice-président SFD
Dr Christine Coffin
CH Périgueux
Mme. Agnès Desserprix
CH Le Creusot, Présidente SFD Paramédical
Pr Michael Joubert
CHU Caen
Dr. Magali Traverso
CHU Montpellier
Dr. Orianne Villard
CHU Montpellier
M. Patrick Mas
Patient expert, associations AFD et Type 1 running team
Evaluated as part of a multicenter clinical study (EkiYou-Study-2)
EkiYou is being evaluated in a prospective, multicenter, randomized, controlled clinical study (NCT06738849), conducted with hospital centers and investigating physicians specializing in diabetes. The objective is to assess its impact on Time in Range (TIR)
Pr. Éric Renard
CHU Montpellier
Pr Hélène Hanaire
CHU Toulouse – Hôpital Rangueil
Pr Emmanuel Cosson
APHP Avicennes
Dr Chloé Amouyal
APHP – Hôpital La Pitié Salpêtrière
Pr Michael Joubert
CHU CAEN
Pr Alfred Penfornis
CHSF Corbeil-Essonnes
Dr Christine Coffin
CH Périgueux
Dr. Pauline Schaeplynck
Fondation Ambroise Paré / HEM
Dr Laurence Salle
CHU Limoges – Dupuytren
Dr Clémence Bures
GH Le Havre – Hôpital Jacques Monod
Dr Said Bekka
Institut de Diabétologie et Nutrition du Centre
Dr Christine Rouby
Clinique Pasteur
Dr Sylvie Picard
Cabinet – Libéral (Dijon)
Anne Navaranne
Cabinet – Libéral (Mérignac)
Marc Diedisheim
Cabinet – Libéral (Saint-Cyr-sur-Loire)
Dr Nathalie Gervaise
Cabinet – Libéral (Saint-Cyr-sur-Loire)
Meet EkiYou Carbs
EkiYou Carbs is a mobile app dedicated to nutritional information and carbohydrate counting. It relies on a rich food database and visual cues that make everyday portion estimation easier.
To help patients, EkiYou Carbs offers a wide range of features:
EkiYou Carbs allows patients to add a meal from a food database containing over 400,000 foods.
EkiYou Carbs allows patients to scan the barcode of commercially available foods.
EkiYou Carbs simplifies the choice of quantities, with functional tools such as the quantification assistant for reasoning with appropriate units for each food, and visual indicators for visualizing the quantity of food according to the size of the dish.
EkiYou Carbs enables patients to export their diary to obtain a complete food record for the last 7, 14 or 30 days.
EkiYou Carbs is a nutrition information mobile application that has been designed with features to facilitate the carb counting routine.
EkiYou Carbs contains a verified food database based on CIQUAL, containing over 400,000 verified foods. This makes it easy for the patient to enter his meal and obtain the amount of carbohydrates contained in it within seconds.
EkiYou Carbs includes features to simplify carbohydrate quantification.
The quantification assistant allows the patient to use appropriate units according to the food chosen: number of spoons, portions, plate size, or grams, to avoid having to weigh the food.
Visual indicators* help to identify the quantity of food in relation to the size of the dish.
Adding foods or whole meals as favorites allows patient to integrate daily eating habits, saving time for future carbohydrate calculations.
*This feature is available for certain foods only.
EkiYou Carbs usage information
Data Processing
The data collected by DiappyMed is stored on certified health data servers (HDS) and processed in accordance with GDPR.
Disclaimer Clauses
*The data contained in the application, including macronutrient calculations, calorie counting, the food database, and articles published in the application, are provided for informational purposes only.
*The application is not intended to diagnose, treat, or advise the user on type 1 diabetes or any other medical condition. It is not intended to replace a medical consultation or treatment.
*For any medical questions or concerns, please contact your doctor or hospital/health center.
*The company does not provide a medical device or medical services through the application in question. The use of the application does not create a medical relationship between the company and the user.
Legal Notice
EkiYou is an application for adults with diabetes under a basal-bolus insulin regimen. It calculates meal bolus recommendations based on glycemia, carbohydrate intake, physical activity and individual insulin parameters. It may also propose adjustment recommendations for basal insulin dose, insulin-to-carbohydrate ratios and correction factor, when the feature is activated and sufficient data are available.
EkiYou provides decision-support recommendations only; it does not deliver insulin and does not control insulin pumps or automated insulin delivery systems. The user must review, confirm or adjust any recommendation before use.
In EkiYou-Study-1, per-protocol analysis of 15 active participants showed a +6.8% increase in Time in Range and a reduction in fear of hypoglycemia.
EkiYou is a CE-marked Class IIb medical device under Regulation (EU) 2017/745. Notified body: CE 1912. Use of EkiYou may expose the patient to risks of hypoglycemia and/or hyperglycemia in the event of incorrect entry of the data required for insulin calculation.
EkiYou does not replace medical advice. Please carefully read the instructions for use before using EkiYou and for full information on risks and precautions.
EkiYou version 2.1.0 (01/07/2026).
Manufacturer: DiappyMed.
Instructions for use: https://diappymed.com/en/ekiyou001ifu-en/.
EkiYou Carbs is not a medical device and does not replace medical advice.
This application is not intended to diagnose, treat, or counsel the user about any pathology and provides only information’s.
